{"first_name":"Prof.","last_name":"Bart Vanhaesebroeck","permalink":"prof-bart-vanhaesebroeck","crunchbase_url":"http://www.crunchbase.com/person/prof-bart-vanhaesebroeck","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Wed Mar 16 12:02:25 UTC 2011","updated_at":"Wed Mar 16 12:05:03 UTC 2011","overview":"<p>Bart Vanhaesebroeck is Professor in Cell Signalling at Barts &amp; the London Medical School at Queen Mary University of London. In 2007, he set up the new Centre for Cell Signalling which studies signal transduction in the broadest sense. He is a world leading expert in PI 3-kinase signalling, a major disease target in oncology and inflammatory diseases. Bart has extensive interactions with Industry at the academic, commercial and consultancy level. He has PhD in Biology/Molecular Biology from Ghent University, in Belgium and previously held positions at the Ludwig Institute for Cancer Research, London and University College London.</p>","image":{"available_sizes":[[[106,106],"assets/images/resized/0012/6477/126477v1-max-150x150.jpg"],[[106,106],"assets/images/resized/0012/6477/126477v1-max-250x250.jpg"],[[106,106],"assets/images/resized/0012/6477/126477v1-max-450x450.jpg"]],"attribution":""},"degrees":[],"relationships":[{"is_past":false,"title":"Founding Director","firm":{"name":"Activiomics","permalink":"activiomics","type_of_entity":"company","image":{"available_sizes":[[[150,35],"assets/images/resized/0012/6473/126473v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0012/6473/126473v1-max-250x250.jpg"],[[310,74],"assets/images/resized/0012/6473/126473v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}